Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-26

Clinical Trial Update: A Study of Adebelimab Combined With Chemotherapy as a First-line Treatment Sequential Treatment for Extensive-stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating adebelimab in combination with chemotherapy as first-line treatment for extensive-stage small cell lung cancer; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adebelimab (adebelimab)
  • Chemotherapy (unspecified)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Extensive-Stage Small Cell Lung Cancer | Phase 2 | Status: NOT_YET_RECRUITING